Gary Rothbard, MD, MS

The phenomenon of cutaneous allodynia is thought to be associated with greater chance for disease progression and lower efficacy of acute therapies.

Patients with migraine and headache disorders who also have photophobia may have greater interictal light sensitivity compared with those without photophobia and healthy individuals.

Flunarizine may be safe, effective, and well-tolerated as a prophylactic treatment for episodic migraine.

Mirogabalin was found to be safe, well tolerated, and effective at alleviating postherpetic neuralgia-associated pain.

A wearing off of responses to onabotulinumtoxinA during the first treatment cycle may be common in individuals with chronic migraine.

Treatment of cervicogenic headache with ultrasound-guided C2 nerve root coblation was associated with significant reductions in pain for at least 24 weeks.

Patients with migraine headaches—particularly those accompanied by aura—may be at significantly increased risk for 30-day hospital readmission because of pain after surgery.